Ewing sarcoma is the second most common tumor of the bone. It most often affects bones of the pelvis, the tibia, fibula, and femur, and can also begin in the soft tissues. This disease most often occurs in adolescents, with nearly half of cases arising between the ages of 10 and 20.
The cause of Ewing sarcoma in children is still unknown. It is not typically associated with any other cancer syndromes. Additionally, there is no additional risk among families in which a single person has Ewing sarcoma.
The Isabella Santos Foundation (ISF) is committed to improving rare pediatric cancer treatment options in an effort to increase survival rates of kids with cancer so they can live their dreams. Our partnership with Levine Children’s Hospital will fund and create the ISF Rare and Solid Tumor Program. This $5 million initiative will be designed to research and treat a wide range of deadly pediatric cancers while allowing the hospital to expand their clinical trials and provide extraordinary patient experience for all children and families with rare and solid tumors.